Familial Cancer

Papers
(The H4-Index of Familial Cancer is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Outcomes of retesting in patients with previously uninformative cancer genetics evaluations35
Cascade genetic testing: an underutilized pathway to equitable cancer care?22
Utility of interim blood tests for cancer screening in Li-Fraumeni syndrome21
Laboratory variation in the grading of dysplasia of duodenal adenomas in familial adenomatous polyposis patients17
Prevalence of cardiometabolic outcomes in women who underwent salpingo-oophorectomy to prevent hereditary breast and ovarian cancer: a meta-analysis15
Collaborative Group of the Americas on Inherited Gastrointestinal Cancers (CGA-IGC) Annual Virtual Meeting, November 13–15, 202114
Colonoscopy surveillance in Lynch syndrome is burdensome and frequently delayed14
Digital innovation for cancer risk assessment allows large-scale service redevelopment of regional cancer genetics service delivery13
Detection of a major Lynch Syndrome-causing MLH1 founder variant in a large-scale genotyped cohort13
Hereditary breast and ovarian cancer genetic testing in unselected patients: example of private supplementation of public healthcare service13
Hereditary acute myeloid leukemia associated with C-terminal CEBPA germline variants12
Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review11
Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review11
0.071449995040894